Internal Medicine, Hematology & Oncology · Muskogee, OK
NPI
1851348700
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
300 Rockefeller Dr
Muskogee, OK, 74401
Phone (918) 684-2187
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
1,375 services
Medicare patients, 2024
433
Average age 74
Drug cost, 2024
$5.3M
2,081 prescriptions
Company payments, 2025
$3,980
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed F Hassany was code 99214 (office e&m - established), 599 times for 236 patients. In total Syed F Hassany billed 1,375 services in 13 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 599 | 236 | $65.28 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 384 | 150 | $11.78 | $4,524 |
| 99213 Office E&M - Established | Facility | 223 | 174 | $40.81 | $9,100 |
| 99204 Office E&M - New | Facility | 57 | 57 | $90.57 | $5,163 |
| 99222 Hospital E&M - Initial | Facility | 49 | 42 | $88.76 | $4,349 |
| 99203 Office E&M - New | Facility | 26 | 26 | $51.68 | $1,344 |
By year: 2022 $173K for 1,990 services; 2023 $97K for 1,322 services; 2024 $66K for 1,375 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed F Hassany prescribed most often to Medicare patients was Anastrozole, with 208 prescriptions and refills. In total Syed F Hassany wrote 2,081 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 208 | 365 | 44 | $3,349 |
| Eliquis Apixaban | 104 | 105 | 19 | $61K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 98 | 98 | 24 | $4,299 |
| Potassium Chloride Generic | 86 | 103 | 25 | $847 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 86 | 86 | 18 | $2,681 |
| Acyclovir Generic | 75 | 99 | 12 | $356 |
| Letrozole Generic | 70 | 88 | Under 11 | $1,441 |
| Hydroxyurea Generic | 66 | 88 | 13 | $1,112 |
| Xtandi Enzalutamide | 63 | 63 | Under 11 | $857K |
| Gabapentin Generic | 60 | 72 | 18 | $492 |
| Fentanyl Generic | 50 | 50 | 11 | $4,889 |
| Revlimid Lenalidomide | 50 | 50 | Under 11 | $1.0M |
| Tasigna Nilotinib Hcl | 44 | 44 | Under 11 | $825K |
| Prednisone Generic | 44 | 52 | 18 | $175 |
| Furosemide Generic | 38 | 38 | Under 11 | $84.86 |
Brand drugs: 479 claims; generic drugs: 1,602 claims; opioid claims: 328.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed F Hassany $3,980 ($3,980 in general payments such as food, travel and fees) from 24 companies. The largest payer was Karyopharm Therapeutics Inc. with $2,853.
| Company | Payments | Amount |
|---|---|---|
| Karyopharm Therapeutics Inc. KPTI | 2 | $2,853 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $224 |
| Pfizer Inc. PFE | 13 | $202 |
| Abbvie Inc. ABBV | 3 | $69.56 |
| Array Biopharma Inc PFE | 3 | $69.13 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $60.66 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $53.04 |
| Daiichi Sankyo Inc. 4568.T | 2 | $50.01 |
| Astellas Pharma US Inc 4503.T | 3 | $48.8 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $48.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.